Analysis on clinical therapeutic effect of donepezil in treating Alzheimer's disease

Hongyu ZhangChinese 2004

Abstract

Objective To investigate the validity and safety of donepezil in treating Alzheimer's disease. Methods 33 cases of Alzheimer's disease were divided randomly into treatment group (18) and control group (15). Treatment group were treated with donepezil and piracetam for 16 weeks, while control group with piracetam only. Alzheimer's disease Assessment Scale-cognitive subscale (ADAS-cog) and Mini Mental State Examination (MMSE) were used to evaluate the patients' cognitive function, mental behavior and dementia severity before and after treatment. Results ADAS-cog and MMSE scores of donepezil treatment group were better significantly than those of control group, and the scores of control group have no remarkable difference between pre- and post-treatment. No obvious drug side effect happened on the patients in treatment group. Conclusion Donepezil can be securely used in the therapy of Alzheimer's disease.
BibTeX
@inproceedings{zhang2004analysis,
  author = {Hongyu Zhang},
  title = {{Analysis on clinical therapeutic effect of donepezil in treating Alzheimer's disease}},
  booktitle = {Chinese},
  year = {2004},
}

Loading related content...

Figure